Clinical spectrum of thrombocytopenia - A hospital based prospective study
DOI:
https://doi.org/10.3126/jpn.v14i2.59384Keywords:
covid-19, Dengue, Platelets, ThrombocytopeniaAbstract
Background: Platelets play a vital role in coagulation. The normal platelet count ranges from 280+/-130 x 109/L. A reduction in platelet count below 150x109/L is defined as thrombocytopenia. The present study was carried out to evaluate the clinico-hematological profile of various patients with thrombocytopenia and to study age and gender-wise distribution, various etiological factors, severity of thrombocytopenia and its association with bleeding manifestations in patients.
Materials and Methods: This prospective study was conducted at the hematology section of the department of Pathology at a tertiary care centre, Ahmedabad, Gujarat, India for a period of two years including 300 patients. EDTA samples were analyzed in5-part automated hematology analyzer. Thrombocytopenia cases were confirmed by peripheral blood smear examination.
Results: Thrombocytopenia was predominant in males (n=178, 59.3%). Most common age group was 20-29 years (n=81, 27%). Major clinical presentation was fever (n= 222, 74%) while bleeding manifestations were observed in only n=25, 8.3% patients. Association of thrombocytopenia with anemia was n=204, (68%) followed by leucopenia (n= 133, 44.3%) and pancytopenia (n=104, 34.6%). Bone marrow examination was done only in 40 (13.3%) patients. The majority had moderate thrombocytopenia (n=124, 41.3%) followed by mild (n=108, 36%). The most common etiology observed was COVID-19 (21%) followed by dengue (17%) and malaria (12.7%).
Conclusions: Thrombocytopenia is a very commonly observed hematological entity. The clinical spectrum of thrombocytopenia is quite varied and ranges from infections to malignancies.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.